Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°©»ó¼± ¿©Æ÷¼±Á¾°ú ¿©Æ÷¾ÏÁ¾¿¡¼­ SPARCÀÇ ¹ßÇö SPARC Expression in Thyroid Follicular Adenomas and Carcinomas

´ëÇѺ´¸®ÇÐȸÁö 2000³â 34±Ç 12È£ p.1016 ~ 1021
±èÁ¤¿­, Á¶¼ºÁø, ±è¹Î°æ, ä¾ç¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¤¿­ ( Kim Chung-Yeul ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Á¶¼ºÁø ( Cho Seong-Jin ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è¹Î°æ ( Kim Min-Kyung ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ä¾ç¼® ( Chae Yang-Seok ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


SPARC, secreted protein acidic and rich in cysteine, is a extracellular matrix-associated protein implicated in the modulation of cell adhesion, migration, cell cycle regulation, and angiogenesis. SPARC is expressed in fibrocytes and endothelial cells involved in tissue repair and invasive malignant tumors in the gastrointestinal tract, breast, lung, kidney, adrenal cortex, ovary, and brain. This study was aimed to characterize the different expression of SPARC in the thyroid follicular adenomas and follicular carcinomas. Immunohistochemical staining was performed in paraffin-embedded tissues of 25 follicular adenomas and 15 follicular carcinomas of the thyroid gland. Immunohistochemically, SPARC was not expressed in the 19 follicular adenoma and 2 follicular carcinoma but highly expressed in the 6 follicular adenoma and 13 follicular carcinoma. These findings suggest that SPARC is a potential diagnostic marker of follicular carcinoma and is helpful to distinguish follicular carcinoma from follicular adenoma without vascular or capsular invasion.

Å°¿öµå

SPARC;Thyroid;Follicular carcinoma;Follicular adenoma

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS